Calming drug tested for breast surgery anxiety
NCT ID NCT07184125
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving midazolam, a sedative, before breast conservation surgery reduces anxiety and improves satisfaction. 124 women were randomly assigned to receive either midazolam or a placebo. Their anxiety was measured before and after the drug, and satisfaction was checked the next day.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Midazolam
- What this could lead to
- If it works, this could point toward a simple way to ease anxiety before breast surgery.
- What could go wrong
- This is a small, single-center trial. The results may not apply to all patients, and midazolam can cause drowsiness or allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shaukat Khanam Cancer Memorial Hospital Lahore
Lahore, Punjab Province, 54000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Virtual reality may distract patients from pain and fear during anesthesia
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Can a VR headset calm nerves before surgery?